DHTKD1 and cancer: This finding suggests that cancer-specific or tissue-specific promoters, many of which have some cancer specificity but are relatively weak at driving transcription, are widely useful for also regulating mutant E1B expression, at least on the condition that E1A expression is regulated by a strictly cancer-specific and strongly active promoter.